Loading…
3 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2022 |
|---|---|
| Revenue | 5,816 |
| EBITDA | 1,476 |
| Net profit | 1,419 |
| Total assets | 5,182 |
| n (companies reporting) | 3 |
GEL, thousands
| Company | FY 2022 |
|---|---|
| Pardi Medikals | 2,862 |
| Lotusi | 1,646 |
| Shik Bebe | 1,309 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.